PSYD_0302: BIRMINGHAM

This record is part of the Psy-ShareD database. The Psy-ShareD database will host pre-existing structural MRI data collected at different global sites that will be suitable for region of interest, voxel-based morphometry, cortical thickness and surface area analytical approaches. To access this database, complete the Data Access Request Form by following the link on this page under the Licence ‘Psy-ShareD Data Access Request’. For more information, follow the link listed in Related Materials.A randomised, double-blind, placebo-controlled trial in participants with a recent-onset schizophrenia-spectrum disorder with continuing positive symptoms.Contributors and PIs: John F. W. DeakinNeuroscience and Psychiatry Unit, The University of Manchester, Manchester, UKInstitute for Mental Health and Centre for Human Brain Health, University of Birmingham, Birmingham, UKKey Details & VariablesData TypeImage data/Feature dataAge Range19-34Number of Participants28Diagnostic CriteriaSCZNumber of Clinical Subjects18Number of Clinical Subjects (follow-up)10Number of Control SubjectsN/ANumber of Control Subjects (follow-up)N/ADemographic InformationAge, Sex, Ethnicity, Handedness, EducationClinical MeasuresPANSS, CDSS, EPS, MAH, COOCognitive MeasuresN/AClinical Functioning MeasuresGAFAntipsychotic Medication Information RecordedYesAntipsychotic Medication Name/ Antipsychotic TypeNameAntipsychotic Dose RecordedYesCPZ Equivalents RecordedN/AOther Medication Variables RecordedYesRecreational Drug/ Alcohol UseYesNote: the above table features key details and variables and is not an exhaustive list.

本条记录属于Psy-ShareD数据库的一部分。Psy-ShareD数据库将托管全球不同地点收集的现有结构化MRI数据，这些数据适用于兴趣区域、体素形态计量学、皮层厚度和表面积分析等研究方法。要访问此数据库，请通过本页下方的“Psy-ShareD数据访问请求”许可链接填写数据访问请求表。欲了解更多信息，请参阅相关材料链接。一项针对近期发病且持续存在阳性症状的精神分裂症谱系障碍参与者的随机、双盲、安慰剂对照试验。贡献者和主要研究者：约翰·F·W·迪金，英国曼彻斯特大学神经科学和精神病学单位，曼彻斯特，英国；英国伯明翰大学心理健康研究所和人类大脑健康中心，伯明翰，英国。关键细节与变量：数据类型为图像数据/特征数据，年龄范围为19-34岁，参与者数量为28人，诊断标准为精神分裂症（SCZ），临床研究对象数量为18人，临床研究对象（随访）数量为10人，对照组受试者数量及随访数量均为零。人口统计学信息包括年龄、性别、种族、手性、教育程度。临床测量指标包括PANSS、CDSS、EPS、MAH、COO。认知测量指标暂无。临床功能测量指标为GAFA。抗精神病药物信息记录情况为是，抗精神病药物名称/抗精神病药物类型记录情况为是，抗精神病药物剂量记录情况为是，CPZ当量记录情况为否，其他药物变量记录情况为是，娱乐性药物/酒精使用情况为是。注意：上述表格展示了关键细节与变量，但非详尽列表。